| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 26, 2007
Accepted on November 26, 2007
AgResearch, Invermay Agricultural Centre, Private Bag 50034, Mosgiel, New Zealand; AgResearch, Wallaceville Animal Research Centre, PO Box 40063, Upper Hutt, New Zealand; School of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, New Zealand
* To whom correspondence should be addressed. E-mail: jenny.juengel{at}agresearch.co.nz.
Growth and differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15, GDF9B) are oocyte–derived proteins essential for the growth and function of ovarian follicles. Moreover, ovine (o) GDF9 and oBMP15 co-operate to increase both 3H-thymidine incorporation and
-inhibin production, and to inhibit progesterone production by rat or ovine granulosa cells. Although the receptors through which these proteins act individually have been determined, the receptor(s) involved in mediating the co-operative effects of GDF9 and BMP15 is (are) unknown. In this study, the effects of the extracellular domains of the Type I and Type II TGF
receptors on 3H-thymidine incorporation by rat granulosa cells stimulated by oGDF9 and oBMP15 were investigated. Stimulation of 3H-thymidine incorporation was completely blocked by the BMP receptor II (BMPRII) extracellular domain but unaffected by any other Type II or any Type I receptor. These results suggest that the initial interaction of oGDF9 and oBMP15 is with BMPRII and that a type I receptor is either recruited or already associated with BMPRII in order to mediate the cooperative effects of these growth factors.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |